Ali Pormohammad
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 9
- Surgery 10
- Infectious Diseases and Tuberculosis 7
- Orthopedic Infections and Treatments 3
- Eosinophilic Esophagitis 3
- Co-authors
- Mohammad Javad Nasiri (15 shared papers)Taher Azimi (7 shared papers)Pourya Gholizadeh (6 shared papers)Ali Hashemi (4 shared papers)Alireza Salimi Chirani (5 shared papers)Seyed Mohammad Riahi (4 shared papers)Hossein Samadi Kafil (2 shared papers)Ramin Pouriran (3 shared papers)
- Journals
- Microbial Pathogenesis (4 papers)Journal of Cellular Physiology (3 papers)Journal of Infection (2 papers)Infection and Drug Resistance (1 paper)Therapeutic Advances in Infectious Disease (1 paper)
- Partner nations
- IranUnited StatesCanada
In The Last Decade
Ali Pormohammad
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 117
- Molecular Medicine 254
- Applied Microbiology and Biotechnology 74
- Microbiology 135
- Periodontics 80
- Infectious Diseases 305
Countries citing papers authored by Ali Pormohammad
This map shows the geographic impact of Ali Pormohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Pormohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Pormohammad more than expected).
Fields of papers citing papers by Ali Pormohammad
This network shows the impact of papers produced by Ali Pormohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Pormohammad. The network helps show where Ali Pormohammad may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Pormohammad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 149 | |
| 2 | 2017 | 121 | |
| 3 | 2017 | 107 | |
| 4 | 2018 | 91 | |
| 5 | 2019 | 83 | |
| 6 | 2017 | 68 | |
| 7 | 2017 | 67 | |
| 8 | 2017 | 58 | |
| 9 | 2018 | 58 | |
| 10 | 2018 | 54 | |
| 11 | 2019 | 48 | |
| 12 | 2017 | 46 | |
| 13 | 2017 | 39 | |
| 14 | 2020 | 35 | |
| 15 | 2020 | 32 | |
| 16 | 2018 | 29 | |
| 17 | Immunocompromised patients with pulmonary tuberculosis; a susceptible group to intestinal parasites. | 2018 | 25 |
| 18 | 2019 | 23 | |
| 19 | 2017 | 22 | |
| 20 | 2019 | 9 |
About Ali Pormohammad
Ali Pormohammad is a scholar working on Infectious Diseases, Surgery, Epidemiology, Molecular Medicine and Molecular Biology, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (9 papers), Infectious Diseases and Tuberculosis (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Antibiotic Resistance in Bacteria (4 papers), Orthopedic Infections and Treatments (3 papers), Streptococcal Infections and Treatments (3 papers), Mycobacterium research and diagnosis (3 papers) and Eosinophilic Esophagitis (3 papers). The work is most often cited by research in Molecular Medicine (254 citations), Applied Microbiology and Biotechnology (74 citations), Microbiology (135 citations), Periodontics (80 citations) and Infectious Diseases (305 citations). Ali Pormohammad has collaborated with scholars based in Iran, United States and Canada. Frequent co-authors include Mohammad Javad Nasiri, Taher Azimi, Pourya Gholizadeh, Ali Hashemi, Alireza Salimi Chirani, Seyed Mohammad Riahi, Hossein Samadi Kafil, Ramin Pouriran, Abbas Ali Imani Fooladi and Hossein Goudarzi. Their work appears in journals such as Microbial Pathogenesis, Journal of Cellular Physiology, Journal of Infection, Infection and Drug Resistance and Therapeutic Advances in Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.